Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
VRTXVertex Pharmaceuticals
FinDog View：Neutral
| Metric | GILD | VRTX |
|---|
| Close | 147.68 | 513.26 |
| Market Cap | $183B | $121B |
| 1M | +6.31% | −0.44% |
| P/E (TTM) | — | 29.7 |
| Forward P/E | 25.3 | 24.0 |
| P/E 5-Yr Percentile | — | 52 |
| P/S | 6.0 | 10.4 |
| P/B | 15.3 | 6.5 |
| Dividend Yield | 3.98% | — |
| Latest Quarter Revenue | $7.8B | $3.3B |
| Revenue YoY | +10.2% | +12.5% |
| Gross Margin | 79.8% | 85.3% |
| Latest Quarter EPS | -8.45 | 4.31 |
| Avg Post-Earnings Move | ±3.8% | ±6.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.01% | 1.66% |
| 90-Day Net Insider Buying | −$15.4M | −$2.8M |
GILD · Revenue, Last 8 Quarters ($B)
VRTX · Revenue, Last 8 Quarters ($B)
